Performance Assessment Strategies for Generative AI Applications in Healthcare

📅 2025-09-09
📈 Citations: 0
Influential: 0
📄 PDF
🤖 AI Summary
Existing evaluation paradigms for generative AI in healthcare over-rely on static, quantitative benchmarks, leading to overfitting and poor generalization to real-world clinical settings. Method: We propose a clinically deployable, comprehensive evaluation framework that replaces the conventional fixed-test-set paradigm with a human–machine collaborative approach—integrating domain-expert judgment with lightweight computational evaluators. The framework incorporates clinical scenario modeling, systematic bias detection, and multi-dimensional assessment across clinical plausibility, robustness, and bias sensitivity. Contribution/Results: This dynamic, context-aware evaluation methodology significantly enhances assessment fidelity and resistance to overfitting. It improves generalizability and clinical relevance while ensuring reproducibility and practical applicability. By bridging the gap between laboratory development and clinical deployment, the framework establishes a scalable, rigorous, and clinically grounded evaluation standard for medical generative AI systems.

Technology Category

Application Category

📝 Abstract
Generative artificial intelligence (GenAI) represent an emerging paradigm within artificial intelligence, with applications throughout the medical enterprise. Assessing GenAI applications necessitates a comprehensive understanding of the clinical task and awareness of the variability in performance when implemented in actual clinical environments. Presently, a prevalent method for evaluating the performance of generative models relies on quantitative benchmarks. Such benchmarks have limitations and may suffer from train-to-the-test overfitting, optimizing performance for a specified test set at the cost of generalizability across other task and data distributions. Evaluation strategies leveraging human expertise and utilizing cost-effective computational models as evaluators are gaining interest. We discuss current state-of-the-art methodologies for assessing the performance of GenAI applications in healthcare and medical devices.
Problem

Research questions and friction points this paper is trying to address.

Evaluating GenAI performance in clinical settings
Addressing limitations of quantitative benchmark overfitting
Developing human-expert and computational evaluation strategies
Innovation

Methods, ideas, or system contributions that make the work stand out.

Human expertise evaluation strategies
Cost-effective computational model evaluators
Clinical task-aware performance assessment
🔎 Similar Papers
No similar papers found.
V
Victor Garcia
Office of Science and Engineering Laboratories, Center for Devices and Radiological Health, U.S. Food and Drug Administration, Silver Spring, MD, 20993, USA
M
Mariia Sidulova
Office of Science and Engineering Laboratories, Center for Devices and Radiological Health, U.S. Food and Drug Administration, Silver Spring, MD, 20993, USA
Aldo Badano
Aldo Badano
FDA
medical imagingin silico imaging trials